TIDMHIK 
 
RNS Number : 5666I 
Hikma Pharmaceuticals Plc 
15 March 2010 
 

 
Block Listing of Shares 
 
                           Hikma Pharmaceuticals PLC 
 
 
 
LONDON, 15 March 2010 - The Board of Hikma Pharmaceuticals PLC ("Hikma") (LSE: 
HIK) (NASDAQ: HIK), announces that it has made a block listing application to 
the Financial Services Authority and the London Stock Exchange plc for a total 
of 700,000 ordinary shares of 10p each in the capital of the Company to be 
admitted to the Official List of the UK Listing Authority.  It is expected that 
admission will be granted on 16 March 2010 and trading will commence on 17 March 
2010. 
 
The shares, when issued, will be issued fully paid and rank pari passu in all 
respects with the existing issued ordinary shares of the Company.  The shares 
will be issued pursuant to the vesting of shares under the Hikma Pharmaceuticals 
PLC 2005 Long Term Incentive Plan (the "Plan"). Participants in the Plan have or 
will become entitled to these shares following the vesting of the shares. 
 
 
For further information, please contact: 
 
Henry Knowles, Company Secretary 
 Hikma Pharmaceuticals 
PLC 
+44 20 7399 2760 
 
Susan Ringdal, Investor Relations Director 
Hikma Pharmaceuticals PLC 
                      +44 20 7399 2760 
 
 
 
 
 
About Hikma 
 
Hikma Pharmaceuticals PLC is a fast growing multinational group focused on 
developing, manufacturing and marketing a broad range of both branded and 
non-branded generic and in-licensed pharmaceutical products.  Hikma's operations 
are conducted through three businesses: "Branded", "Injectables" and "Generics". 
 Hikma's operations are based principally in the Middle East and North Africa 
("MENA") region, where it is a market leader and sells across 17 countries, the 
United States and Europe.  In 2008, the Group achieved revenues of $580.7 
million (2007 $449 million) and profit attributable to shareholders was $57.1 
million (2007 $63 million).  For news and other information, please visit 
www.hikma.com. 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 BLRKKPDQCBKKBND
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.